Jason Drew Smith insider trades

Open-market stock purchases and sales by Jason Drew Smith, General Counsel at UroGen Pharma Ltd, from SEC Form 4 filings since Sep 9, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +73%.

Recent trades

DateStockTradeValue
Feb 3, 2026URGN UroGen Pharma LtdSold$52.3K
Feb 3, 2026URGN UroGen Pharma LtdSold$31.7K
Feb 3, 2026URGN UroGen Pharma LtdSold$63.3K
Jan 31, 2026URGN UroGen Pharma LtdBought (not open market)—
Jan 31, 2026URGN UroGen Pharma LtdBought (not open market)—
Jan 31, 2026URGN UroGen Pharma LtdBought (not open market)—
Jan 31, 2026URGN UroGen Pharma LtdBought (not open market)—

Companies traded

  • URGN UroGen Pharma Ltd: 1 buy, 21 sales, last Feb 3, 2026

Get free alerts when Jason Drew Smith files a new trade →